This dual action of obestatin to trigger FoxO inactivation by obestatin highlights the importance of turning off FoxO in wasting disorder‐related skeletal muscle atrophy, possibly to ensure a tight response to obestatin to counteract catabolic activity. This evidence concerns the gene GHRL and muscle atrophy.